hit counter

Maxalt (Rizatriptan) Side Effects & Adverse Reactions (List)

Maxalt (Rizatriptan) is a pharmaceutical medication engineered by Merck & Co. for the treatment of migraine headaches (with or without aura).  It received FDA approval in 1998 as an abortive antimigraine intervention and is chemically classified as a second-generation triptan (tryptamine-based).  Analogous to other triptans, Rizatriptan remains ineffective as a migraine prophylactic, however, it is …

Read more